Publications by authors named "Ray Sheridan"

Claim this Profile
H
Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.
Leila Janani, Alasdair P S Munro, Annie Wright, Parvinder K Aley, Gavin Babbage, Ray Sheridan

J Infect· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Management of severe and fulminant infection in adults.
Daisy Usbell, Nicola Louise Maddox, Ray Sheridan

J Med Microbiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of severe and fulminant infection in adults.
Daisy Ubsdell, Nicola Louise Maddox, Ray Sheridan

J Med Microbiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.
David Devos, Olivier Rascol, Wassilios G Meissner, Alexandra Foubert-Samier, Simon Lewis, Ray Sheridan

J Parkinsons Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Ana Westenberger, Volha Skrahina, Tatiana Usnich, Christian Beetz, Eva-Juliane Vollstedt, Ray Sheridan

Brain· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
Olivia Bird, Eva P Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Ray P Sheridan

Epidemiol Infect· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.
Ivan T Lee, Catherine A Cosgrove, Patrick Moore, Claire Bethune, Rhiannon Nally, Ray Sheridan

Lancet Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
Xinxue Liu, Alasdair P S Munro, Annie Wright, Shuo Feng, Leila Janani, Ray Sheridan

J Infect· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
Xinxue Liu, Alasdair Ps Munro, Shuo Feng, Leila Janani, Parvinder K Aley, Ray Sheridan

J Infect· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Paul T Heath, Eva P Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Ray P Sheridan

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Alasdair P S Munro, Shuo Feng, Leila Janani, Victoria Cornelius, Parvinder K Aley, Ray Sheridan

Lancet Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Xinxue Liu, Alasdair P S Munro, Shuo Feng, Leila Janani, Parvinder K Aley, Ray Sheridan

J Infect· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Alasdair P S Munro, Leila Janani, Victoria Cornelius, Parvinder K Aley, Gavin Babbage, Ray Sheridan

Lancet· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
Paul T Heath, Eva P Galiza, David N Baxter, Marta Boffito, Duncan Browne, Ray P Sheridan

N Engl J Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
Julie Bruce, Anower Hossain, Ranjit Lall, Emma J Withers, Susanne Finnegan, Ray Sheridan

Health Technol Assess· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse encephalitic toxoplasmosis in HIV.
Jasmine Pearce, Ray Sheridan, Johnathan Shaw, Thomas Senior

BMJ Case Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and Intervention to Prevent Falls and Fractures in Older People.
Sarah E Lamb, Julie Bruce, Anower Hossain, Chen Ji, Roberta Longo, Ray Sheridan

N Engl J Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of different frailty domains in a population based sample in England.
Solveig A Arnadottir, Julie Bruce, Ranjit Lall, Emma J Withers, Martin Underwood, Ray Sheridan

BMC Geriatr· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and development of a complex multifactorial falls assessment intervention for falls prevention: The Prevention of Falls Injury Trial (PreFIT).
Julie Bruce, Shvaita Ralhan, Ray Sheridan, Katharine Westacott, Emma Withers

BMC Geriatr· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cluster randomised controlled trial of advice, exercise or multifactorial assessment to prevent falls and fractures in community-dwelling older adults: protocol for the prevention of falls injury trial (PreFIT).
Julie Bruce, Ranjit Lall, Emma J Withers, Susanne Finnegan, Martin Underwood, Ray Sheridan

BMJ Open· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant.
Melissa Baxter, Tariq Ahmad, Alaric Colville, Ray Sheridan

Clin Infect Dis· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An osteoporotic fracture mimicking cervical dystonia in idiopathic Parkinson's disease.
Caroline Ostrowski, Lindsay Ronan, Ray Sheridan, Vaughan Pearce

Age Ageing· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection.
Emma Butt, Jane A H Foster, Edward Keedwell, Julia E A Bell, Richard W Titball, Ray Sheridan

BMC Infect Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning and switching between stimulus-saccade associations in Parkinson's disease.
Timothy L Hodgson, Petroc Sumner, Dimitra Molyva, Ray Sheridan, Christopher Kennard

Neuropsychologia· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ASCOT on hypertension treatment and guidelines in older adults.
Ray Sheridan, Neil Baldwin

Age Ageing· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis